Penthrox approved in Italy, The Czech Republic and Spain
16 July 2018
ASX Announcement
Penthrox approved in Italy, The Czech Republic and Spain.
Medical Developments International Limited (ASX: MVP) is delighted to announce that Penthrox has been approved for sale in Italy,?the Czech Republic and Spain.
MVP CEO, Mr. John Sharman said, ?We are delighted to have received the approval for these countries and we expect sales to commence in these markets during FY19. This leaves just two further European approvals pending ? Luxembourg and Lithuania, with these approvals considered imminent.”
For the actual ASX announcements, please refer to the attached links – Penthrox approved in Italy and the Czech Republic and Penthrox approved in Spain